Pharmacokinetic profile of ABELCET (amphotericin B lipid complex injection): combined experience from phase I and phase II studies. [electronic resource]
Producer: 19971124Description: 2201-8 p. digitalISSN:- 0066-4804
- Amphotericin B -- administration & dosage
- Antifungal Agents -- administration & dosage
- Antineoplastic Agents -- adverse effects
- Area Under Curve
- Chromatography, High Pressure Liquid
- Drug Combinations
- Drug Interactions
- HIV Infections -- metabolism
- Half-Life
- Humans
- Kidney Diseases -- metabolism
- Leishmaniasis, Mucocutaneous -- metabolism
- Mycoses -- metabolism
- Neutropenia -- metabolism
- Phosphatidylcholines -- administration & dosage
- Phosphatidylglycerols -- administration & dosage
- Reference Values
No physical items for this record
Publication Type: Clinical Trial; Clinical Trial, Phase I; Clinical Trial, Phase II; Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.
There are no comments on this title.
Log in to your account to post a comment.